Cirrhosis and Complications Flashcards

1
Q

Overview of Portal Circulation

A
  • In cirrhosis: liver is hard 2/2 fibrosis and circulatory factors triggers vasoconstriction.
  • Blood which should enter liver from portal vein instead backs up into varices. This is a high pressure process, lymphatics cannot compensate, and ascites then develops.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cirrhosis Pathophysiology.

A
  • Pressure = flow x resistance.
  • Cirrhosis causes increased mechanical resistance to portal flow, thus increased portal pressures.
  • Intrahepatic vascular resistance is affected by decrease in vasodilators and increase in vasoconstrictors.
  • Vasocactive substances causes decreased splanchnic arteriolar resistance which increases portal flow and further increases portal pressure; splanchnic circulation is also increased by hyper dynamic circulation
  • Increased Na+ retention leads to increased vascular volume.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 levels of portal hypertension

A
  • Pre-sinusoidal (no liver disease): portal vein obstruction.
  • Sinusoidal (intrinsic liver disease is present): Cirrhosis, infiltrative disease.
  • Post sinusoidal: Blood cannot get out of the liver: Budd-Chiari syndrome, constrictive pericarditis.

Portal vein-> Sinusoidal-> Hepatic Vein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Extra (pre)hepatic portal HTN

A
  • Portal Vein thrombosis
  • Anatomical obstruction of portal vein (tumor)
  • AV fistula
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Intahepatic portal HTN: Cirrhosis

A
  • Hepatocellular disease: hepatitis (can lead to cirrhosis)
  • Biliary disease: BA, PSC (can lead to cirrhosis).
  • Vascular disease: Nodular regenerative hyperplasia (NRH), Sinusoidal obstruction syndrome (SOS). occurs after chemo/radiation.
  • Fibrosis: congenital hepatic fibrosis. (a/w polycystic kidney)
  • Other
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

anastomosing pattern of bile ducts in broad band of fibrosis is seen in congenital hepatic fibrosis.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nodular Regenerative Hyperplasia: nodules pressing on vessels

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Post hepatic causes of portal HTN: when blood cannot exit the liver. centrilobular necrosis from lack of blood outflow.

A

Budd Chiari
HV thrombosis or IVC thrombosis
Pericardititis (restrictive)
R-sided heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diagnosis of portal HTN

A

-PE: splenomegaly, ascites
- thrombocytopenia, leukopenia
- US: increased echo texture of cirrhotic liver, ascites, splenomegaly, reversal of portal vein flow
- EGD: vases, portal HTN gastropathy
- HVPG: Difference between wedged hepatic venous pressure (shows portal vein pressure) and free hepatic vein pressure. HVPG>12 is associated with varices and ascites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ascites: physiology

A
  • Vasodilation and effective hypovolemia result in stimulation the RAAS, salt and water are retained.
  • Portal HTN increases hydrostatic pressure in splanchnic circulation, exceeding capacity of lymphatics
  • Low albumin decreases colloid oncotic pressure, allowing fluid to leak into interstitium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DDX of ascites

A
  • Hepatic: cirrhosis or severe hepatitis or ALF
  • Circulatory: Right heart failure or Budd- Chiara syndrome
  • Cancer
  • Inflammatory: pancreatitis
  • Renal/proteinuria: nephrotic syndrome.
  • Infectious: TB or bacterial peritonitis
  • Mixed: cirrhosis + secondary etiology
  • Myxedema ascites (hypothyroidism)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Evaluation of Ascites

A
  • PMN count >250/cc3 indicates SBP
  • Culture
  • Protein/glucose: High serum-ascites albumin gradient >1.1 is seen in chronic liver disease
  • LDH
  • Amylase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ascites in liver disease has low protein content

A
  • High serum-ascites albumin gradient >1.1 g/dl is seen in chronic liver disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SBP

A
  • Definition: infection of ascites fluid
  • Sis: fever, and pain, non-specific worsening
  • Dx: PMN>250/cc3, +culture
  • Bugs: pneumococcus, gram-negative rods
  • Tx: IV abx,
  • Prevention: PO antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of Ascites in Cirrhosis

A
  • Mild Na restriction
  • Diuretics: spironolactone (inhibits aldosterone (acts distally): 2-3mc/kig/d)
    Lasix: loop diuretic: 1-2mg/kg/d
    -Albumin inclusion: 1g/kg of 25% albumin +lasix
  • Paracentesis +/- albumin
  • TIPS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Variceal Bleeding

A
  • RF: spleen size, plt count, liver synthetic function
  • Management: acute resuscitation, correct coagulation, antibiotics, PPI prophylaxis, Octreotide (vasoactive), EGD: EBL: sclerotherapy, ?cyanoacrylate for gastric varies.
    -Shunts: TIPS, surgical, transplant.
16
Q

REX shunt: used for extra-hepatic portal HTN

A

Mesenteric vein to coral vein shunt, restores anterograde flow through liver in extra hepatic portal vein obstruction.
- only used for patient with portal vein thrombosis

17
Q

Hepatopulmonary syndrome vs
Portopulmonary HTN

A
  • HPS, tiny shunts develop within the lung: SOB, digital clubbing, diagnostic testing: bubble echo with R to L shunting of bubbles within 3-5 beats. Management: transplant.
  • PPH: fatigue, chest pain, SOB. Diagnostic etsting: cardiac Cath with measurements. Management: transplant is contraindicated when pressures are very high.
18
Q

Hepatorenal Syndrome

A
  • Compensated cirrhosis: splanchnic vasodilation, low effective arteriolar blood volume, and heart compensates
    vs
  • Decompensated cirrhosis: splanchnic vasodilation, RAAS actives, kidneys vasoconstriction, hepatorenal syndrome
19
Q

Hepatorenal syndrome

A
  • renal dysfunction, kidney is vasoconstrictor.
    DDX: pre renal, ATN, intrinsic kidney disease
    Management: fluid management, bolus trial, avoid intravascular volume depletion, NSAIDS, ahminoglycosides
  • Vasoactive drugs/albumin, octreotide
    HRS resolves after liver transplantation, consider kidney transplant if dialysis for >2 months
20
Q

Hyponatremia

A

Cirrosis/portal HTN -> splanchnic/systemic vasodilation, -> decreased effective arterial blood volume –> activation of neurohumoral systems –> renal tubule/water retention –> dilution hyponatremia

21
Q

Portosystemic Encephalopathy

A
  • build up of ammonia, can be seen in advanced liver disease, precipitated by bleed, infection, drugs.
  • Tx: lactulose, Rifaximin, Flagyl